• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

A framework for interpreting genome-wide association studies of psychiatric disorders.

Genome-wide association studies (GWAS) have yielded a plethora of new findings in the past 3 years. By early 2009, GWAS on 47 samples of subjects with attention-deficit hyperactivity disorder, autism, bipolar disorder, major depressive disorder and schizophrenia will be completed. Taken together, these GWAS constitute the largest biological experiment ever conducted in psychiatry (59 000 independent cases and controls, 7700 family trios and >40 billion genotypes). We know that GWAS can work, and the question now is whether it will work for psychiatric disorders. In this review, we describe these studies, the Psychiatric GWAS Consortium for meta-analyses of these data, and provide a logical framework for interpretation of some of the conceivable outcomes.

Pubmed ID: 19002139

Authors

  • Psychiatric GWAS Consortium Steering Committee

Journal

Molecular psychiatry

Publication Data

January 19, 2009

Associated Grants

  • Agency: Medical Research Council, Id: G9810900

Mesh Terms

  • Genome
  • Genome-Wide Association Study
  • Humans
  • Mental Disorders
  • Meta-Analysis as Topic